FDA Drug information
Bimatoprost
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Bimatoprost BIMATOPROST .3 mg/mL Alembic Pharmaceuticals Inc.
- Bimatoprost BIMATOPROST .3 mg/mL Alembic Pharmaceuticals Inc.
- Bimatoprost BIMATOPROST .3 mg/mL Alembic Pharmaceuticals Limited
- Bimatoprost BIMATOPROST .3 mg/mL Alembic Pharmaceuticals Limited
- Bimatoprost BIMATOPROST .3 mg/mL Apotex Corp.
- Bimatoprost BIMATOPROST .3 mg/mL Aurobindo Pharma Limited
- Bimatoprost BIMATOPROST .3 mg/mL Fosun Pharma USA Inc.
- Bimatoprost BIMATOPROST .3 mg/mL Fosun Pharma USA Inc.
- Bimatoprost BIMATOPROST .3 mg/mL Fosun Pharma USA Inc.
- Bimatoprost BIMATOPROST .3 mg/mL Sandoz Inc
- Bimatoprost BIMATOPROST .3 mg/mL Somerset Therapeutics, LLC
- Bimatoprost BIMATOPROST .3 mg/mL Somerset Therapeutics, LLC
- Bimatoprost BIMATOPROST .3 mg/mL Somerset Therapeutics, LLC
- Bimatoprost BIMATOPROST 3 ug/mL Akorn
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.